Andreas Neumayr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andreas Neumayr has a total of 257 co-authors. Here are the top co-authors by number of shared publications:
- Esther Kuenzli
Swiss Tropical and Public Health Institute, Basel, Switzerland
8 shared publications Beatrice Nickel
Swiss Tropical and Public Health Institute, Department of Medicine, Diagnostic Centre , Kreuzstrasse 2, 4123 Allschwil
6 shared publicationsEsther Kuenzli
University of Basel, Basel, Switzerland; Swiss Tropical and Public Health Institute, Allschwil, Switzerland
6 shared publications- Afona Chernet
Swiss Tropical and Public Health Institute, Allschwil, Switzerland
4 shared publications - Beatrice Nickel
Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland
4 shared publications Christoph Hatz
Swiss Tropical and Public Health Institute Basel, Basel, Switzerland
4 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (10) , 5575
Chikungunya case cluster with nonspecific symptoms: implications for primary care in Switzerland
BACKGROUND: Early clinical presentation of chikungunya fever and other arbovirus infections is often nonspecific, potentially delaying diagnosis, particularly in settings where these diseases are less frequently considered. Competent vectors are expanding in Switzerland, increasing the risk of autochthonous arbovirus transmission. CASE SERIES: We report seven cases in a group of travellers returning from Kenya in summer 2025. All patients presented with fever, arthralgia affecting the small joints of the hands and feet, nausea, diarrhoea, and rash. Additional symptoms included generalised lymphadenopathy and peripheral oedema. Initial diagnostic tests were inconclusive, with negative results on rapid diagnostic tests for chikungunya antibodies, dengue antibodies, and malaria antigen. The definitive diagnosis was established after 35 days following the emergence of chikungunya IgG and IgM antibodies. DISCUSSION: The presentation resembled a nonspecific febrile illness. Repeated, appropriately timed laboratory testing was necessary to establish the diagnosis. Early diagnostic results may be misleading, particularly when testing methods are not selected appropriately for the stage of the disease. With competent mosquito vectors established in Switzerland, imported cases present a risk of local transmission. Severe infections and persistent joint pain may lead to long-term disability. CONCLUSION: Primary care doctors should consider chikungunya fever in returning travellers and, during the mosquito-active season, in non-travellers in areas with established competent vectors. Patients may present with symptoms ranging from nonspecific febrile illness to more typical manifestations of chikungunya, including fever, arthralgia of the small joints, and rash. Appropriate test selection, timing, and repeated testing when indicated are essential for accurate diagnosis, management, and documentation of the disease.
- 1 October 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (10) , 5575
Open AccessChikungunya case cluster with nonspecific symptoms: implications for primary care in Switzerland
BACKGROUND: Early clinical presentation of chikungunya fever and other arbovirus infections is often nonspecific, potentially delaying diagnosis, particularly in settings where these diseases are less frequently considered. Competent vectors are expanding in Switzerland, increasing the risk of autochthonous arbovirus transmission. CASE SERIES: We report seven cases in a group of travellers returning from Kenya in summer 2025. All patients presented with fever, arthralgia affecting the small joints of the hands and feet, nausea, diarrhoea, and rash. Additional symptoms included generalised lymphadenopathy and peripheral oedema. Initial diagnostic tests were inconclusive, with negative results on rapid diagnostic tests for chikungunya antibodies, dengue antibodies, and malaria antigen. The definitive diagnosis was established after 35 days following the emergence of chikungunya IgG and IgM antibodies. DISCUSSION: The presentation resembled a nonspecific febrile illness. Repeated, appropriately timed laboratory testing was necessary to establish the diagnosis. Early diagnostic results may be misleading, particularly when testing methods are not selected appropriately for the stage of the disease. With competent mosquito vectors established in Switzerland, imported cases present a risk of local transmission. Severe infections and persistent joint pain may lead to long-term disability. CONCLUSION: Primary care doctors should consider chikungunya fever in returning travellers and, during the mosquito-active season, in non-travellers in areas with established competent vectors. Patients may present with symptoms ranging from nonspecific febrile illness to more typical manifestations of chikungunya, including fever, arthralgia of the small joints, and rash. Appropriate test selection, timing, and repeated testing when indicated are essential for accurate diagnosis, management, and documentation of the disease.
- Open Access
- 24 April 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (4) , e270728
Konzo: a nutrition-related tropical spastic paraparesis
Konzo, derived from the Yaka term for ‘tired legs ’ (Democratic Republic of the Congo, DRC) and also known as Buka-buka in the Bandundu region of DRC, is a nutrition-related neurotoxic disorder confined to sub-Saharan Africa. It predominantly affects impoverished and underserved rural populations who depend on bitter cassava as a dietary staple. Cases of konzo most often arise during the dry season or prolonged droughts, when limited water availability hinders adequate soaking or processing of cassava roots, preventing the effective removal of their toxic cyanide content prior to consumption. Clinically, konzo presents as an acute-onset, symmetrical, isolated motor disorder characterised by non-progressive yet permanent spastic paraparesis. In the absence of a curative treatment, the lifelong consequences of konzo impose a substantial burden on affected individuals and their communities.
- 24 April 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (4) , e270728
Open AccessKonzo: a nutrition-related tropical spastic paraparesis
Konzo, derived from the Yaka term for ‘tired legs ’ (Democratic Republic of the Congo, DRC) and also known as Buka-buka in the Bandundu region of DRC, is a nutrition-related neurotoxic disorder confined to sub-Saharan Africa. It predominantly affects impoverished and underserved rural populations who depend on bitter cassava as a dietary staple. Cases of konzo most often arise during the dry season or prolonged droughts, when limited water availability hinders adequate soaking or processing of cassava roots, preventing the effective removal of their toxic cyanide content prior to consumption. Clinically, konzo presents as an acute-onset, symmetrical, isolated motor disorder characterised by non-progressive yet permanent spastic paraparesis. In the absence of a curative treatment, the lifelong consequences of konzo impose a substantial burden on affected individuals and their communities.
- Open Access
- 29 October 2025
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (1) , 104254
Unbiased DNA Pathogen Detection in Tissues: Real-World Experience With Metagenomic Sequencing in Pathology
- 29 October 2025
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (1) , 104254
Open AccessUnbiased DNA Pathogen Detection in Tissues: Real-World Experience With Metagenomic Sequencing in Pathology
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Viable Schistosoma mansoni infection 41 years after last exposure—a case report of a loyal parasite
Highlight: Schistosoma species may show extraordinary longevity, despite not replicating in human hosts. We present a case of active Schistosoma mansoni infection in a Swiss patient 41 years after her one and only possible exposure (swimming in Lake Kivu, Rwanda).
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Viable Schistosoma mansoni infection 41 years after last exposure—a case report of a loyal parasite
Highlight: Schistosoma species may show extraordinary longevity, despite not replicating in human hosts. We present a case of active Schistosoma mansoni infection in a Swiss patient 41 years after her one and only possible exposure (swimming in Lake Kivu, Rwanda).
- Open Access
- 2 October 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Dirofilariasis presenting with recurrent solitary erythematous swellings and creeping dermatitis
Highlight: A 24-year-old Swiss medical student with an extensive travel history presented to the general practitioner with solitary erythematous migratory swellings on her lower leg. A diagnosis was finally reached after 6 months, when a creeping eruption presented on her eyelid.
- 2 October 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Open AccessDirofilariasis presenting with recurrent solitary erythematous swellings and creeping dermatitis
Highlight: A 24-year-old Swiss medical student with an extensive travel history presented to the general practitioner with solitary erythematous migratory swellings on her lower leg. A diagnosis was finally reached after 6 months, when a creeping eruption presented on her eyelid.
- Open Access
- 8 August 2025
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 14 (1) , 83
The Basel ultrasonography protocol for assessing hepatosplenic pathologies in Asian schistosomiasis: report of a WHO expert meeting
Asian hepatointestinal schistosomiasis due to Schistosoma japonicum is prevalent in the Philippines and in Indonesia, while it is close to elimination in China. The second Asian schistosome, S. mekongi, is found in Cambodia and Laos. The main pathology caused by both species is liver fibrosis, which can cause significant morbidity and mortality, mainly due to portal hypertension leading to bleeding from esophageal varices. Ultrasonography was introduced several decades ago as a safe, fast, non-invasive, and relatively inexpensive technique for assessing chronic schistosomiasis-related hepatic pathology in the clinical and field settings. A standardized ultrasound protocol had been established by experts at a WHO-chaired meeting in Cairo, Egypt, in 1990. The peculiarities of sonomorphologic abnormalities caused by S. japonicum and S. mekongi were not sufficiently covered in the Cairo protocol and not addressed at all in the subsequent WHO chaired meeting in Niamey 1996. At a follow-up WHO-chaired meeting in Phnom Pehnh, Cambodia, in 2002, an attempt was made to develop a protocol for Asian schistosomiasis, but a protocol resulting from this meeting has never been published. Although several studies investigated the use of ultrasonography to assess S. japonicum- and S. mekongi-related sonomorphological morbidity across endemic areas the lack of a standardized protocol hampered the characterization of sonomorphologic abnormalities with regard to progression, reversibility, prognosis, and correlation to morbidity. In addition, the comparison of data from different endemic areas and populations remained difficult. Therefore, a WHO-chiared expert meeting took place in Basel, Switzerland in September 2024 with the aim to establish a standardized ultrasound protocol for reporting the pathology caused by S. japonicum and S. mekongi. The proposed protocol is described in this article. Graphical Abstract
- 8 August 2025
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 14 (1) , 83
Open AccessThe Basel ultrasonography protocol for assessing hepatosplenic pathologies in Asian schistosomiasis: report of a WHO expert meeting
Asian hepatointestinal schistosomiasis due to Schistosoma japonicum is prevalent in the Philippines and in Indonesia, while it is close to elimination in China. The second Asian schistosome, S. mekongi, is found in Cambodia and Laos. The main pathology caused by both species is liver fibrosis, which can cause significant morbidity and mortality, mainly due to portal hypertension leading to bleeding from esophageal varices. Ultrasonography was introduced several decades ago as a safe, fast, non-invasive, and relatively inexpensive technique for assessing chronic schistosomiasis-related hepatic pathology in the clinical and field settings. A standardized ultrasound protocol had been established by experts at a WHO-chaired meeting in Cairo, Egypt, in 1990. The peculiarities of sonomorphologic abnormalities caused by S. japonicum and S. mekongi were not sufficiently covered in the Cairo protocol and not addressed at all in the subsequent WHO chaired meeting in Niamey 1996. At a follow-up WHO-chaired meeting in Phnom Pehnh, Cambodia, in 2002, an attempt was made to develop a protocol for Asian schistosomiasis, but a protocol resulting from this meeting has never been published. Although several studies investigated the use of ultrasonography to assess S. japonicum- and S. mekongi-related sonomorphological morbidity across endemic areas the lack of a standardized protocol hampered the characterization of sonomorphologic abnormalities with regard to progression, reversibility, prognosis, and correlation to morbidity. In addition, the comparison of data from different endemic areas and populations remained difficult. Therefore, a WHO-chiared expert meeting took place in Basel, Switzerland in September 2024 with the aim to establish a standardized ultrasound protocol for reporting the pathology caused by S. japonicum and S. mekongi. The proposed protocol is described in this article. Graphical Abstract
- 4 June 2025
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 20 (02) , 141-155
Malaria – Klinik, Diagnostik und Management
Infolge des regen internationalen Reiseverkehrs werden in der Schweiz jährlich bis zu 350 und in Deutschland bis zu 1000 Malariafälle bei Reiserückkehrern verzeichnet. Dieser Übersichtsartikel hat zum Ziel, die wichtigsten diagnostischen und therapeutischen Aspekte des klinischen Managements der Malaria bei Reiserückkehrern praxisorientiert zu diskutieren und zusammenzufassen. Article published online: 04 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 4 June 2025
- Published by Georg Thieme Verlag KG in Krankenhaushygiene up2date
- Vol. 20 (02) , 141-155
Malaria – Klinik, Diagnostik und Management
Infolge des regen internationalen Reiseverkehrs werden in der Schweiz jährlich bis zu 350 und in Deutschland bis zu 1000 Malariafälle bei Reiserückkehrern verzeichnet. Dieser Übersichtsartikel hat zum Ziel, die wichtigsten diagnostischen und therapeutischen Aspekte des klinischen Managements der Malaria bei Reiserückkehrern praxisorientiert zu diskutieren und zusammenzufassen. Article published online: 04 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 23 April 2025
- Published by Georg Thieme Verlag KG in Reisemedizin up2date
- Vol. 02 (02) , 121-135
Malaria – Klinik, Diagnostik und Management
Infolge des regen internationalen Reiseverkehrs werden in der Schweiz jährlich bis zu 350 und in Deutschland bis zu 1000 Malariafälle bei Reiserückkehrern verzeichnet. Dieser Übersichtsartikel hat zum Ziel, die wichtigsten diagnostischen und therapeutischen Aspekte des klinischen Managements der Malaria bei Reiserückkehrern praxisorientiert zu diskutieren und zusammenzufassen. Article published online: 23 April 2025 © 2025. Thieme. All rights reserved. CRM Centrum für Reisemedizin GmbH Burgunderstraße 31, 40549 Düsseldorf, Germany
- 23 April 2025
- Published by Georg Thieme Verlag KG in Reisemedizin up2date
- Vol. 02 (02) , 121-135
Malaria – Klinik, Diagnostik und Management
Infolge des regen internationalen Reiseverkehrs werden in der Schweiz jährlich bis zu 350 und in Deutschland bis zu 1000 Malariafälle bei Reiserückkehrern verzeichnet. Dieser Übersichtsartikel hat zum Ziel, die wichtigsten diagnostischen und therapeutischen Aspekte des klinischen Managements der Malaria bei Reiserückkehrern praxisorientiert zu diskutieren und zusammenzufassen. Article published online: 23 April 2025 © 2025. Thieme. All rights reserved. CRM Centrum für Reisemedizin GmbH Burgunderstraße 31, 40549 Düsseldorf, Germany
- Open Access
- 1 November 2024
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 30 (11) , 2432-2435
Suspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru
Suspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru
- 1 November 2024
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 30 (11) , 2432-2435
Open AccessSuspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru
Suspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru
- Open Access
- 12 September 2024
- Published by Springer Nature in Malaria Journal
- Vol. 23 (1) , 1-2
Malaria and typhoid fever co-infection - a retrospective analysis of University Hospital records in Nigeria
- 12 September 2024
- Published by Springer Nature in Malaria Journal
- Vol. 23 (1) , 1-2
Open AccessMalaria and typhoid fever co-infection - a retrospective analysis of University Hospital records in Nigeria